In our previous study, TM4SF1 was also up-regulated in CRC patients, and regulated metastatic potential of CRC cells via the activation of EMT regulators, MMP-2/9, VEGF, and β-catenin [32,33]. The gene discussed is MMP2; the disease is colorectal carcinoma.